Lineage Cell Therapeutics
LCTX
#8906
Rank
C$0.28 B
Marketcap
C$1.11
Share price
-5.87%
Change (1 day)
-54.88%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -C$37.48 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$13.08 Million. In 2025 the company made an earning of -C$31.24 Million a decrease over its 2024 earnings that were of -C$30.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$37.48 Million19.97%
2025 -C$31.24 Million1.4%
2024 -C$30.81 Million-13.16%
2023 -C$35.47 Million9.83%
2022 -C$32.3 Million-54.24%
2021 -C$70.58 Million86.07%
2020 -C$37.93 Million-31.97%
2019 -C$55.76 Million-5.42%
2018 -C$58.95 Million1.1%
2017 -C$58.31 Million-31.06%
2016 -C$84.57 Million-10.38%
2015 -C$94.37 Million29.69%
2014 -C$72.77 Million31.68%
2013 -C$55.27 Million
2011 -C$26.82 Million89.78%
2010 -C$14.14 Million206.06%
2009 -C$4.62 Million-0.58%
2008 -C$4.65 Million164.89%
2007 -C$1.76 Million-30.22%
2006 -C$2.52 Million
2002 -C$2.92 Million-41.04%
2001 -C$4.95 Million-32.04%
2000 -C$7.29 Million-11.85%
1999 -C$8.27 Million
1997 -C$5.31 Million12.12%
1996 -C$4.74 Million106.25%
1995 -C$2.3 Million-11.11%
1994 -C$2.59 Million50%
1993 -C$1.73 Million20%
1992 -C$1.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion 481.52%๐Ÿ‡บ๐Ÿ‡ธ USA